“…Liver receptor homolog-1 (LRH-1, NR5A2) is one of two members of the NR5A receptor subclass, sharing a high degree of sequence identity (DBD, 95%; LBD, 76%) with steroidogenic factor-1 (SF-1, NR5A1) (Sablin et al, 2003). Both LRH-1 and SF-1 contribute to regulating steroidogenesis, but recent evidence has shown that LRH-1 plays a far more ubiquitous role also contributing to the regulation of bile acid, glucose, and ll cholesterol homeostasis (Oosterveer et al, 2012;Stein et al, 2014;Miranda et al, 2018), embryogenesis (Fayard et al, 2004), ovulation (Bianco et al, 2019), pregnancy (Zhang et al, 2013;Meinsohn et al, 2019), pancreatic and breast cancer (Lai et al, 2013;Pang et al, 2017;, inflammatory bowel disease (Bayrer et al, 2018), type I and II diabetes (Lee et al, 2011;Cobo-Vuilleumier et al, 2018), and nonalcoholic fatty liver disease (Stein et al, 2017). In contrast to classical dimeric nuclear receptors, NR5A receptors are obligate monomers that recognize a 9-bp motif containing a 5 0 -extension past the classical AGGYCR nucleotide sequence (Fayard et al, 2004;Solomon et al, 2005;Little et al, 2006).…”